Uber stock jumps nearly 6% as CES robotaxi reveal with Lucid, Nuro lifts shares

Uber stock jumps nearly 6% as CES robotaxi reveal with Lucid, Nuro lifts shares

New York, January 6, 2026, 18:36 EST — After-hours

  • Uber shares rose about 6% as it showcased a robotaxi partnership at CES in Las Vegas
  • The Lucid-based vehicle uses Nuro’s Level 4 self-driving system and Nvidia computing, the companies said
  • Investors are watching rollout timing, partnership economics and early-February earnings calendars next

Uber Technologies, Inc. shares rose $4.79, or 5.9%, to $85.54 in late trade on Tuesday after the ride-hailing company and partners Lucid Group and Nuro unveiled a production-intent robotaxi at CES. The stock traded between $80.85 and $85.64 on the day, and about 27.5 million shares changed hands.

The move matters because robotaxis are resurfacing as a key swing factor for ride-hailing valuations, with investors weighing whether autonomous fleets expand demand or pressure pricing. For Uber, the question is how much of each fare it can keep as the vehicles and software increasingly come from partners rather than drivers.

Uber sold its self-driving unit to Aurora Innovation in 2020 and has since positioned itself as a platform partner to bring robotaxis onto its app, rather than building the technology in-house. The CES debut puts Uber in a fast-moving field that includes Alphabet’s Waymo and Tesla, as companies push from testing into early commercial service. Reuters

Uber, Lucid and Nuro said the robotaxi is based on Lucid’s Gravity electric SUV and runs Nuro’s Level 4 autonomous system — designed to drive itself in set areas and conditions without human input — on Nvidia’s DRIVE AGX Thor platform. On-road testing began in December in the San Francisco Bay Area with safety operators, and production is expected to start later this year at Lucid’s Arizona factory, pending final validation, the companies said. Uber executive Sarfraz Maredia called the effort a way to “bring a state-of-the-art robotaxi to market later this year,” while Nuro co-CEO Dave Ferguson pointed to “delivering autonomy at scale.” Uber Investor Relations

Still, the partnership model carries risk if robotaxi operators demand a larger share of each fare, squeezing Uber’s take rate — the portion of the trip price it keeps. Melius Research analysts Conor Cunningham and Patrick Coleman this week cut Uber to “sell” and lowered their price target, citing intensifying robotaxi competition and uncertainty around long-term margins. Barron’s

Traders will be looking for clearer signals on timing, economics and regulatory pathways as testing expands and the partners move toward a Bay Area launch. Wall Street calendars list Uber’s next quarterly results around Feb. 4 before the opening bell, though the company has not confirmed a date; a nearer market catalyst is Friday’s U.S. jobs report at 8:30 a.m. ET. Yahoo Finance

Stock Market Today

  • Summit Therapeutics valuation under the microscope after share strength; P/B at 74.8x, DCF fair value $217.67
    January 7, 2026, 8:37 PM EST. Summit Therapeutics (SMMT) rose 1.9% on the day and 8.7% over the week, though longer-term returns remain uneven: 30 days up 2.07%, 90 days down 16.07%, and a three-year total shareholder return that highlights patient holders' gains despite near-term momentum cooling. On a P/B basis, the stock trades at 74.8x price against a US$19.01 share price, far above the industry average of 2.7x and a peer average of 11.2x, signaling the market expects a stronger future than the balance sheet implies. A DCF model puts fair value at US$217.67 versus last close of US$19.01, suggesting potential discount based on cash flow scenarios. The narrative flags OVERVALUED P/B and UNDERVALUED DCF; risk remains, including ongoing net losses of US$921.617 and potential ivonescimab trial failures.
Exxon Mobil stock slides 3% as oil falls on Venezuela supply bets; investors eye next catalyst
Previous Story

Exxon Mobil stock slides 3% as oil falls on Venezuela supply bets; investors eye next catalyst

Coinbase (COIN) stock slips after-hours as CEO sale-plan filing follows Goldman upgrade
Next Story

Coinbase (COIN) stock slips after-hours as CEO sale-plan filing follows Goldman upgrade

Go toTop